vs

Side-by-side financial comparison of Epsilon Energy Ltd. (EPSN) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.

Epsilon Energy Ltd. is the larger business by last-quarter revenue ($14.8M vs $9.2M, roughly 1.6× Foghorn Therapeutics Inc.). Epsilon Energy Ltd. runs the higher net margin — -83.9% vs -234.3%, a 150.3% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 65.7%). Over the past eight quarters, Epsilon Energy Ltd.'s revenue compounded faster (36.2% CAGR vs 35.3%).

Epsilon Composite is a French company created in 1987 by Stephane LULL, its current CEO. The company was founded in January 1987. Its production site is located in Gaillan, France. Stéphane Lull is the CEO.

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.

EPSN vs FHTX — Head-to-Head

Bigger by revenue
EPSN
EPSN
1.6× larger
EPSN
$14.8M
$9.2M
FHTX
Growing faster (revenue YoY)
FHTX
FHTX
+158.0% gap
FHTX
223.8%
65.7%
EPSN
Higher net margin
EPSN
EPSN
150.3% more per $
EPSN
-83.9%
-234.3%
FHTX
Faster 2-yr revenue CAGR
EPSN
EPSN
Annualised
EPSN
36.2%
35.3%
FHTX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EPSN
EPSN
FHTX
FHTX
Revenue
$14.8M
$9.2M
Net Profit
$-12.4M
$-21.7M
Gross Margin
Operating Margin
-129.0%
-258.2%
Net Margin
-83.9%
-234.3%
Revenue YoY
65.7%
223.8%
Net Profit YoY
-1535.0%
-11.1%
EPS (diluted)
$-0.55
$-0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EPSN
EPSN
FHTX
FHTX
Q4 25
$14.8M
$9.2M
Q3 25
$9.0M
$8.2M
Q2 25
$11.6M
$7.6M
Q1 25
$16.2M
$6.0M
Q4 24
$8.9M
$2.9M
Q3 24
$7.3M
$7.8M
Q2 24
$7.3M
$6.9M
Q1 24
$8.0M
$5.0M
Net Profit
EPSN
EPSN
FHTX
FHTX
Q4 25
$-12.4M
$-21.7M
Q3 25
$1.1M
$-15.8M
Q2 25
$1.6M
$-17.9M
Q1 25
$4.0M
$-18.8M
Q4 24
$-760.8K
$-19.5M
Q3 24
$366.0K
$-19.1M
Q2 24
$815.7K
$-23.0M
Q1 24
$1.5M
$-25.0M
Operating Margin
EPSN
EPSN
FHTX
FHTX
Q4 25
-129.0%
-258.2%
Q3 25
6.7%
-226.9%
Q2 25
7.1%
-279.2%
Q1 25
44.3%
-385.0%
Q4 24
6.8%
-840.5%
Q3 24
3.3%
-305.5%
Q2 24
16.0%
-386.6%
Q1 24
17.6%
-558.3%
Net Margin
EPSN
EPSN
FHTX
FHTX
Q4 25
-83.9%
-234.3%
Q3 25
11.9%
-194.4%
Q2 25
13.3%
-237.3%
Q1 25
24.8%
-316.4%
Q4 24
-8.5%
-682.9%
Q3 24
5.0%
-244.9%
Q2 24
11.2%
-333.6%
Q1 24
18.9%
-495.4%
EPS (diluted)
EPSN
EPSN
FHTX
FHTX
Q4 25
$-0.55
$-0.35
Q3 25
$0.05
$-0.25
Q2 25
$0.07
$-0.28
Q1 25
$0.18
$-0.30
Q4 24
$-0.04
$-0.23
Q3 24
$0.02
$-0.31
Q2 24
$0.04
$-0.45
Q1 24
$0.07
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EPSN
EPSN
FHTX
FHTX
Cash + ST InvestmentsLiquidity on hand
$9.0M
$80.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$124.7M
$-108.5M
Total Assets
$228.2M
$198.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EPSN
EPSN
FHTX
FHTX
Q4 25
$9.0M
$80.9M
Q3 25
$12.8M
$89.3M
Q2 25
$9.9M
$72.6M
Q1 25
$6.9M
$61.0M
Q4 24
$6.5M
$55.5M
Q3 24
$8.3M
$57.7M
Q2 24
$8.6M
$138.9M
Q1 24
$2.3M
$79.3M
Stockholders' Equity
EPSN
EPSN
FHTX
FHTX
Q4 25
$124.7M
$-108.5M
Q3 25
$100.2M
$-89.7M
Q2 25
$100.2M
$-76.7M
Q1 25
$99.7M
$-61.7M
Q4 24
$96.7M
$-45.5M
Q3 24
$98.4M
$-28.3M
Q2 24
$99.6M
$-14.3M
Q1 24
$99.9M
$-97.5M
Total Assets
EPSN
EPSN
FHTX
FHTX
Q4 25
$228.2M
$198.1M
Q3 25
$126.3M
$205.0M
Q2 25
$123.6M
$226.2M
Q1 25
$125.5M
$258.7M
Q4 24
$120.5M
$284.0M
Q3 24
$121.8M
$308.4M
Q2 24
$121.1M
$328.6M
Q1 24
$125.1M
$255.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EPSN
EPSN
FHTX
FHTX
Operating Cash FlowLast quarter
$-277.0K
$-22.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EPSN
EPSN
FHTX
FHTX
Q4 25
$-277.0K
$-22.3M
Q3 25
$4.0M
$-18.9M
Q2 25
$8.3M
$-21.0M
Q1 25
$8.6M
$-24.0M
Q4 24
$5.0M
$-24.5M
Q3 24
$2.7M
$-21.0M
Q2 24
$5.4M
$-25.5M
Q1 24
$3.7M
$-29.3M
Free Cash Flow
EPSN
EPSN
FHTX
FHTX
Q4 25
Q3 25
Q2 25
$-21.0M
Q1 25
$-24.0M
Q4 24
$-25.0M
Q3 24
$-21.3M
Q2 24
$-25.6M
Q1 24
$-29.4M
FCF Margin
EPSN
EPSN
FHTX
FHTX
Q4 25
Q3 25
Q2 25
-278.2%
Q1 25
-403.2%
Q4 24
-875.3%
Q3 24
-273.0%
Q2 24
-371.0%
Q1 24
-583.1%
Capex Intensity
EPSN
EPSN
FHTX
FHTX
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.3%
Q1 25
0.5%
Q4 24
16.8%
Q3 24
4.0%
Q2 24
0.2%
Q1 24
2.0%
Cash Conversion
EPSN
EPSN
FHTX
FHTX
Q4 25
Q3 25
3.70×
Q2 25
5.38×
Q1 25
2.14×
Q4 24
Q3 24
7.50×
Q2 24
6.60×
Q1 24
2.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EPSN
EPSN

Gas Oil Ngls And Condensate$13.3M90%
Gas Gathering And Compression$1.5M10%

FHTX
FHTX

Segment breakdown not available.

Related Comparisons